Immunohistochemical detection of oxidative stress biomarkers, dityrosine and Nε-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 4, 2008, Pages 185-192

  Fukuchi, Yoshiko ^a   Miura, Yoko ^a   Nabeno, Yuka ^a   Kato, Yoji ^b   Osawa, Toshihiko ^c   Naito, Michitaka ^a  

^a SUGIYAMA JOGAKUEN UNIVERSITY   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; C reactive protein; Dityrosine; N (hexanoyl)lysine

Indexed keywords

EID: 56349131321     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E543     Document Type: Article

References (31)

1. Inoue N: Vascular C-reactive protein in the pathogenesis of coronary artery disease: role of vascular inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets, 2006; 6:227-231
2. Singh U and Jialal I: Oxidative stress and atherosclerosis. Pathophysiology, 2006; 13:129-142
3. Venugopal SK, Devaraj S, and Jialal I: C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation, 2003; 108:1676-1678
4. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, and Yokoyama M: Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol, 2003; 23:1398-1404
5. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, Harrison DG, Quyyumi AA, and Vaccarino V: Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis, 2005; 178:115-121
6. Hulthe J and Fagerberg B: Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol, 2002; 22:1162-1167
7. Daví G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, and Patrono C: Platelet activation in obese women: role of inflammation and oxidant stress. JAMA, 2002; 288:2008-2014
8. Kato Y, Wu X, Naito M, Nomura H, Kitamoto N, and Osawa T: Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody. Biochem Biophys Res Commun, 2000; 275:11-15
9. Kato Y, Maruyama W, Naoi M, Hashizume Y, and Osawa T: Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett, 1998; 439:231-234
10. ε-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem, 1999; 274:20406-20414
11. Kato Y, Miyake Y, Yamamoto K, Shimomura Y, Ochi H, Mori Y, and Osawa T: Preparation of a monoclonal antibody to N(epsilon)-(Hexanonyl)lysine: application to the evaluation of protective effects of flavonoid supplementation against exercise-induced oxidative stress in rat skeletal muscle. Biochem Biophys Res Commun, 2000; 274:389-393
12. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, and Fan J: C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol, 2005; 167:1139-1148
13. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, and Heinecke JW: Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem, 1997; 272:3520-3526
14. Endo K, Miyashita Y, Sasaki H, Ebisuno M, Ohira M, Saiki A, Koide N, Oyama T, Takeyoshi M, and Shirai K: Probucol and atorvastatin decrease urinary 8-hydroxy-2′-deoxyguanosine in patients with diabetes and hypercholesterolemia. J Atheroscler Thromb, 2006; 13:68-75
15. Kinoshita M, Kawamura M, Fujita M, Hirota D, Suda T, Taki M, Kusano J, Takao K, Takenaka H, Kubota S, and Teramoto T: Enhanced susceptibility of LDL to oxidative modification in a CTX patient: -role of chenodeoxycholic acid in xanthoma formation. J Atheroscler Thromb, 2004; 11:167-172
16. Guan JZ, Murakami H, Yamato K, Tanabe J, Matsui J, Tamasawa N, and Suda T: Effects of fluvastatin in type 2 diabetic patients with hyperlipidemia: reduction in cholesterol oxidation products and VCAM-1. J Atheroscler Thromb, 2004; 11:56-61
17. Naito M, Wu X, Nomura H, Kodama M, Kato Y, Kato Y, and Osawa T: The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb, 2002; 9:243-250
18. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res, 1994; 74:1141-1148
19. Matsubara T and Ziff M: Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol, 1986; 137:3295-3298
20. Mohazzab KM, Kaminski PM, and Wolin MS: NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol, 1994; 266:H2568-H2572
21. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG: Angiotensin II- mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest, 1996; 97:1916-1923
22. Klebanoff SJ: Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med, 1980; 93:480-489
23. Babior BM, Kipnes RS, and Curnutte JT: biological defense mechanisms, The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest, 1973; 52:741-744
24. Babior BM: NADPH oxidase: an update. Blood, 1999; 93:1464-1476
25. Heinecke JW, Li W, Daehnke HL 3rd, and Goldstein JA: Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem, 1993; 268:4069-4077
26. Heinecke JW, Li W, Francis GA, and Goldstein JA: Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest, 1993; 91:2866-2872
27. Bhattacharjee S, Pennathur S, Byun J, Crowley J, Mueller D, Gischler J, Hotchkiss RS, and Heinecke JW: NADPH oxidase of neutrophils elevates o,o'-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys, 2001; 395:69-77
28. Savenkova ML, Mueller DM, and Heinecke JW: Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem, 1994; 269:20394-20400
29. Gieseg SP, Pearson J, and Firth CA: Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free Radic Res, 2003; 37:983-991
30. Kato Y, Kitamoto N, Kawai Y, and Osawa T: The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine. Free Radic Biol Med, 2001; 31:624-632
31. Zwaka TP, Hombach V, and Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation, 2001; 103:1194-1197